Bimagrumab (Anti-ACVR2B)

Bimagrumab (Anti-ACVR2B) is a human monoclonal antibody targeting activin type II receptor (ActRII). It can be used for the treatment of pathological muscle loss and weakness. MW : 150 KD.
Supplier Selleck Chemicals
Product # A2595
Sku # A2595-1mg*5
Pricing 1mg*5, $970.00
Feedback